Hydrogen Protects Mice from Radiation Induced Thymic Lymphoma in BALB/c Mice by Zhao, Luqian et al.
Int. J. Biol. Sci. 2011, 7 
 
 
http://www.biolsci.org 
297 
I In nt te er rn na at ti io on na al l   J Jo ou ur rn na al l   o of f   B Bi io ol lo og gi ic ca al l   S Sc ci ie en nc ce es s   
2011; 7(3):297-300 
Letter to Editor 
Hydrogen Protects Mice from Radiation Induced Thymic Lymphoma in 
BALB/c Mice   
Luqian Zhao1#, Chuanfeng Zhou1#,Jian Zhang2#, Fu Gao1, Bailong Li1, Yunhai Chuai1, Cong Liu1, Jianming 
Cai1 
1.  Department of Radiation Medicine, Second Military Medical University, Xiangyin Road, Shanghai 200433, PR China. 
2.  Department of Surgery, Changzheng Hospital, Second Military Medical University, Xiangyin Road, 200433, Shanghai, PR 
China.  
# These authors contributed equally to this work.  
 Corresponding author: Jianming Cai & Cong Liu. Address: Department of Radiation Medicine, Second Military Medical 
University; 800, Xiangyin Road 200433, Shanghai; P.R. China Fax: +86-21-81871150. E-mail: caijianming882003@163.com & 
victorliu20102020@smmu.edu.cn. 
© Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/ 
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. 
Received: 2011.03.19; Accepted: 2011.03.20; Published: 2011.03.25 
Abstract 
Ionizing radiation (IR) is a well-known carcinogen, however the mechanism of radiation in-
duced thymic lymphoma is not well known. Moreover, an easy and effective method to 
protect mice from radiation induced thymic lymphoma is still unknown. Hydrogen, or H2, is 
seldom regarded as an important agent in medical usage, especially as a therapeutic gas. Here 
in this study, we found that H2 protects mice from radiation induced thymic lymphoma in 
BALB/c mice. 
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Introduction 
Ionizing radiation (IR) is a well-known carcino-
gen  for  various  human  tissues  and  a  complete  car-
cinogen that is able to both initiate and promote tu-
mor  progression  [1,2,3].  The  mechanism  for  this 
promotion is poorly understood, but studies of mouse 
thymic  lymphomas  provide  some  hints  [2,4,5,6,7,8]. 
Indeed,  studies  of  radiation-induced  mouse  thymic 
lymphomas,  one  of  the  classic  models  in  radiation 
carcinogenesis,  demonstrated  that  multi-steps  and 
many factors, like Ras, Pten and Fas, were involved in 
radiation-induced carcinogenesis [4,7]. Our previous 
studies showed that ERK1/2, STAT3 and SHP-2 are 
also involved in radiation induced thymic lymphoma 
formation in BALB/c mice [9]. However, an easy and 
effective  method  to  protect  mice  from  radia-
tion-induced  thymic  lymphoma  is  still  not  well 
known [1,10].  
Hydrogen  (H2),  the  most  abundant  chemical 
element in the universe (constituting approximately 
75% of the universe’s elemental mass), is seldom re-
garded as an important agent in medical usage, espe-
cially  as  a  therapeutic  gas.  However,  many  recent 
studies by our lab and other labs provided evidence 
that H2 gas has powerful therapeutic and preventive 
effects  for  many  diseases  [11,12,13].  Ohsawa  et  al. 
found that molecular H2 could selectively reduce cy-
totoxic  reactive  oxygen  species,  such  as  hydroxyl 
radicals  in  vitro  and  exert  therapeutic  antioxidant 
activity  in  a  rat  middle  cerebral  artery  occlusion 
model in vivo [11]. Since hydroxyl is very strong ox-
idants that react indiscriminately with nucleic acids, 
lipids and proteins resulting in DNA fragmentation, 
lipid peroxidation and protein inactivation, they are 
also the main mediators of radiation damage [12]. We Int. J. Biol. Sci. 2011, 7 
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hypothesized  and  showed  by  experimental  studies 
that  H2  treatment  could  protect  cultured  cells  and 
mice from radiation damage [12,13,14]. In those stud-
ies, we used a single high dose model to find that H2 is 
a novel protective gas on radiation induced injuries. 
Importantly, those previous studies also showed that 
H2-rich saline/water is safe, easy to administer and 
cost-effective [13,14]. 
In  this  study,  we  used  a  split  dose  radia-
tion-induced  thymic  lymphoma  model  in  BALB/c 
mice to test the potential role of H2 on radiation in-
duced carcinogenesis in a method very similar to our 
previously studies [9,13,14].  
Materials and Experimental Design 
Radiation induced thymic lymphoma model was 
described by many groups and our previous studies 
[4,5,9].  In  detail,  male  wild-type  BALB/c  mice,  5-6 
weeks of age, were purchased from Chinese academy 
of science (Shanghai, China) and A 60Co irradiator was 
introduced for total-body ionizing irradiation as de-
scribed  in  our  previous  work  [9,12,13,14,15].  Four 
weekly sub-lethal doses of 1.75 Gy gamma-ray irra-
diation were delivered to 5-6 week old BALB/c mice 
at a dose rate of 0.58Gy/min as described previously 
[9].  Only  two  groups  were  used  in  this  study:  the 
H2-rich saline group (H2 (+) group) or normal saline 
control (H2 (-) group) as described previously [13,14]. 
Themice from these two groups were intraperitonealy 
injected with H2-rich saline (H2 (+) group) or normal 
saline (H2 (-) group) 5 minutes before each irradiation 
respectively as we described detailed in our previous 
work [13,14]. 
Results and Discussion 
We  found  that  H2  treatment  significantly  in-
creased the survival rate of mice 30 weeks’ after split 
dose radiation (Figure 1A, P<0.05).This datum is con-
sistent  with  our  previous  studies  that  H2 treatment 
could protect cultured cells and mice from radiation 
damage [12,13,14]. 
 
 
Figure 1. Hydrogen treatment protected BALB/c mice from radiation-induced thymic lymphoma. Four weekly sub-lethal 
doses of 1.75 Gy gamma-ray irradiation were delivered to 4 week old BALB/c mice at a dose rate of 0.58Gy/min as described 
previously [9]. These mice were intraperitonealy injected with either H2-rich saline (H2 group, H2 (+)) or normal saline 
(Control group, H2 (-)) 5 minutes before each irradiation as described previously [13,14].  Panel A; Survival curve analysis of 
control and H2 treated mice after split irradiation (N=40). Panel B; tumor incidence at 20 weeks post last irradiation was 
analyzed by histological study (N=20, 3 repeats). Panel C; Mean latent Period was calculated (N=20, 3 repeats).  Int. J. Biol. Sci. 2011, 7 
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Figure 2. H2 pre-treatment reduced split radiation- induced ROS levels. BALB/c mice, 5-6 weeks of age, were subjected 
with IR (IR group) or without IR (Non-IR group). IR protocol was the four weekly sub-lethal doses of 1.75 Gy gamma-ray 
irradiation at a dose rate of 0.58Gy/min [9]. These mice were also intraperitonealy injected with H2-rich saline (H2 (+) group) 
or with normal saline (H2 (-) group) 5 minutes before each irradiation respectively as we described in detail in our previous 
work [13,14]. Then 4 hours after the last irradiation, PBMC and serum from these mice were prepared and the ROS levels 
were measured with our published methods (N=6, 3 repeats). Panel A: PBMC from BALB/c mice, with or without IR, with 
or without H2, 4 hours after last IR were prepared and subjected to FACS assay to detect the DCFH-DA ROS level. MFI: 
Mean Fluorescence Intensity; (N=6, 3 repeats). Panel B-D; Serum from BALB/c mice, with or without IR, with or without H2, 
4 hours after last IR were prepared and subjected to ELISA assay for detection of SOD, GSH and MDA level with or our 
published method [13,14]. B: SOD; C: GSH; D: MDA; (N=6, 3 repeats). 
 
However,  the  radiation-induced  thymic  lym-
phoma  rate  in  the  H2  (+)  group  was  significantly 
lower  than  in  the  control  group  (Figure  1B  P<0.05) 
and H2 treatment significantly increased the latency of 
lymphoma development after the split dose irradia-
tion (Figure 1C). These data indicated that H2 protects 
mice  from  radiation  induced  thymic  lymphoma  in 
BALB/c mice. 
The detrimental effects of IR on biological tissues 
can  be  mediated  via  increased  production  of  free 
radicals  and  reactive  oxygen  species  (ROS)  and  the 
ROS system have been found to play important role in 
the induction of cancers [1,8,16].  
To explore the potential role of  ROS  in  H2 in-
duced protection of radiation induced carcinogenesis, 
we used different methods to detect changes in intra-
cellular  and  extracellular  ROS  levels  in  H2  treated 
mice and control mice 4h after the last irradiation [13]. 
Intracellular ROS levels in peripheral blood mononu-
clear cells (PBMC) from irradiated and control mice 
were assessed using FACS analysis with DCFH-DA 
(2′7′di-chlorofluorescein diacetate), which converts to 
highly fluorescent DCF in the presence of intracellular 
ROS. As shown in Figure 2A, ROS levels were much 
lower in the irradiated H2 group than in the irradiated 
control mice. Similar results were also found for ROS 
levels in extracellular serum. Serum SOD (Superoxide 
dismutase)  and  total  GSH  (Glutathione)  concentra-Int. J. Biol. Sci. 2011, 7 
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tions at 4h after the last irradiation in the H2 group 
were  significantly  higher  than  that  of  the  control 
group, while MDA (Malondialdehyde) concentrations 
in the H2 group were significantly lower than that of 
the control group (Figure 2B, 2C and 2D). These re-
sults indicate that the H2 pre-treated groups showed 
an increased antioxidant status, consistent  with our 
previous studies that showed that H2 could reduce 
radiation-induced  free  radical  damage  to  DNA 
[13,14]. 
Radiation therapy is now a routine treatment for 
certain types of cancer and over 20 percent of cancer 
patients  will  require  radiation  therapy  during  the 
treatments of their disease [16,17]. Radiation itself can 
induce  many  types  of  cancers,  especially  leukemia 
and lymphomas, but few simple protective methods 
have been found.  
To the best of our knowledge, this may be the 
first report describing treatment with H2, which re-
duced the risk of radiation-induced carcinogenesis in 
the BALB/c mouse model. While the therapeutic ef-
fectiveness of H2 treatment on radiation carcinogene-
sis  needs  further  study,  this  work  provides  some 
novel experimental evidence for the use of H2 in ra-
diation therapy. Since it is safe, easy to administer and 
cost-effective, it could not only protect against radia-
tion induced death [12,13,14], but also attenuate the 
rate of radiation induced carcinogenesis. 
Conclusion  
In conclusion, our data indicates that H2 protects 
mice  from  radiation  induced  thymic  lymphoma  in 
BALB/c mice. 
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